Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Cancelled Post Market

Current status date:

2012-12-31

Original market date: See footnote 1

1999-09-20

Product name:

STEMGEN

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

02240229

Product Monograph/Veterinary Labelling:

Date: 2009-01-26 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

BIOVITRUM AB (PUBL)
Strandbergsgatan 49
Stockholm
Saone Et Loire
Sweden  11276

Class: 

Human

Dosage form(s):

Kit,  Powder For Solution

Route(s) of administration:

Subcutaneous

Number of active ingredient(s):

2

Schedule(s):

Schedule D,  Prescription  

American Hospital Formulary Service (AHFS): See footnote 3

20:16.00   HEMATOPOIETIC AGENTS

Anatomical Therapeutic Chemical (ATC): See footnote 4

L03AA12  ANCESTIM

Active ingredient group (AIG) number:See footnote 5

0237442003

List of active ingredient(s)
Active ingredient(s) Strength
ANCESTIM 1875 MCG / VIAL
WATER 5 ML / VIAL

Application information

Related information

Contact us

Version 3.7.1
Date modified: